MannKind Corporation (MNKD)
USD 4.76
(-2.56%)
USD 4.76
(-2.56%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 721.36 Million USD | 32.16% |
| 2022 | 545.82 Million USD | 2.89% |
| 2021 | 530.51 Million USD | 83.55% |
| 2020 | 289.02 Million USD | 1.68% |
| 2019 | 284.25 Million USD | 0.52% |
| 2018 | 282.78 Million USD | -5.52% |
| 2017 | 299.3 Million USD | 2.98% |
| 2016 | 290.65 Million USD | -39.03% |
| 2015 | 476.74 Million USD | 1.82% |
| 2014 | 468.2 Million USD | 61.81% |
| 2013 | 289.35 Million USD | -20.07% |
| 2012 | 361.99 Million USD | -29.46% |
| 2011 | 513.2 Million USD | 10.89% |
| 2010 | 462.78 Million USD | 50.93% |
| 2009 | 306.61 Million USD | 56.66% |
| 2008 | 195.72 Million USD | 9.13% |
| 2007 | 179.34 Million USD | 14.78% |
| 2006 | 156.25 Million USD | 630.34% |
| 2005 | 21.39 Million USD | 63.06% |
| 2004 | 13.12 Million USD | -8.25% |
| 2003 | 14.29 Million USD | 2.14% |
| 2002 | 14 Million USD | 0.0% |
| 2000 | 10.75 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 669.61 Million USD | -5.8% |
| 2024 Q1 | 710.84 Million USD | -1.46% |
| 2023 Q4 | 721.36 Million USD | 26.09% |
| 2023 Q1 | 553.53 Million USD | 1.41% |
| 2023 Q2 | 573.9 Million USD | 3.68% |
| 2023 Q3 | 572.1 Million USD | -0.31% |
| 2023 FY | 721.36 Million USD | 32.16% |
| 2022 Q4 | 545.82 Million USD | 2.69% |
| 2022 Q3 | 531.51 Million USD | -0.25% |
| 2022 FY | 545.82 Million USD | 2.89% |
| 2022 Q1 | 540.38 Million USD | 1.86% |
| 2022 Q2 | 532.85 Million USD | -1.39% |
| 2021 Q4 | 530.51 Million USD | 25.45% |
| 2021 Q3 | 422.89 Million USD | -3.08% |
| 2021 Q1 | 493 Million USD | 70.57% |
| 2021 FY | 530.51 Million USD | 83.55% |
| 2021 Q2 | 436.34 Million USD | -11.49% |
| 2020 Q2 | 282.49 Million USD | 1.52% |
| 2020 Q4 | 289.02 Million USD | 2.46% |
| 2020 Q1 | 278.26 Million USD | -2.11% |
| 2020 FY | 289.02 Million USD | 1.68% |
| 2020 Q3 | 282.1 Million USD | -0.14% |
| 2019 Q4 | 284.25 Million USD | 1.57% |
| 2019 FY | 284.25 Million USD | 0.52% |
| 2019 Q3 | 279.84 Million USD | 0.74% |
| 2019 Q2 | 277.79 Million USD | -3.87% |
| 2019 Q1 | 288.96 Million USD | 2.18% |
| 2018 FY | 282.78 Million USD | -5.52% |
| 2018 Q1 | 285.08 Million USD | -4.75% |
| 2018 Q4 | 282.78 Million USD | 12.76% |
| 2018 Q3 | 250.79 Million USD | -6.69% |
| 2018 Q2 | 268.77 Million USD | -5.72% |
| 2017 Q3 | 307.49 Million USD | 2.29% |
| 2017 FY | 299.3 Million USD | 2.98% |
| 2017 Q2 | 300.61 Million USD | 5.88% |
| 2017 Q1 | 283.91 Million USD | -2.32% |
| 2017 Q4 | 299.3 Million USD | -2.66% |
| 2016 Q2 | 506.01 Million USD | 8.41% |
| 2016 Q1 | 466.73 Million USD | -2.1% |
| 2016 FY | 290.65 Million USD | -39.03% |
| 2016 Q3 | 334.81 Million USD | -33.83% |
| 2016 Q4 | 290.65 Million USD | -13.19% |
| 2015 Q1 | 457.05 Million USD | -2.38% |
| 2015 Q4 | 476.74 Million USD | 18.42% |
| 2015 Q2 | 468.02 Million USD | 2.4% |
| 2015 Q3 | 402.58 Million USD | -13.98% |
| 2015 FY | 476.74 Million USD | 1.82% |
| 2014 Q2 | 282.68 Million USD | 36.55% |
| 2014 FY | 468.2 Million USD | 61.81% |
| 2014 Q4 | 468.2 Million USD | 9.52% |
| 2014 Q3 | 427.49 Million USD | 51.23% |
| 2014 Q1 | 207.01 Million USD | -28.46% |
| 2013 Q3 | 455.33 Million USD | 24.82% |
| 2013 FY | 289.35 Million USD | -20.07% |
| 2013 Q4 | 289.35 Million USD | -36.45% |
| 2013 Q2 | 364.78 Million USD | 0.77% |
| 2013 Q1 | 362 Million USD | 0.0% |
| 2012 FY | 361.99 Million USD | -29.46% |
| 2012 Q2 | 484.76 Million USD | -8.33% |
| 2012 Q3 | 486.57 Million USD | 0.37% |
| 2012 Q4 | 361.99 Million USD | -25.6% |
| 2012 Q1 | 528.8 Million USD | 3.04% |
| 2011 FY | 513.2 Million USD | 10.89% |
| 2011 Q3 | 504.82 Million USD | 6.56% |
| 2011 Q1 | 458.25 Million USD | -0.98% |
| 2011 Q2 | 473.74 Million USD | 3.38% |
| 2011 Q4 | 513.2 Million USD | 1.66% |
| 2010 Q2 | 377.21 Million USD | 9.59% |
| 2010 Q4 | 462.78 Million USD | -4.89% |
| 2010 FY | 462.78 Million USD | 50.93% |
| 2010 Q1 | 344.19 Million USD | 12.26% |
| 2010 Q3 | 486.58 Million USD | 28.99% |
| 2009 Q4 | 306.61 Million USD | 5.35% |
| 2009 FY | 306.61 Million USD | 56.66% |
| 2009 Q3 | 291.06 Million USD | 1.63% |
| 2009 Q2 | 286.39 Million USD | 18.08% |
| 2009 Q1 | 242.53 Million USD | 23.92% |
| 2008 Q4 | 195.72 Million USD | 16.36% |
| 2008 FY | 195.72 Million USD | 9.13% |
| 2008 Q1 | 167.32 Million USD | -6.7% |
| 2008 Q2 | 173.96 Million USD | 3.96% |
| 2008 Q3 | 168.2 Million USD | -3.31% |
| 2007 Q4 | 179.34 Million USD | -2.8% |
| 2007 FY | 179.34 Million USD | 14.78% |
| 2007 Q3 | 184.51 Million USD | 8.56% |
| 2007 Q2 | 169.95 Million USD | 1.6% |
| 2007 Q1 | 167.28 Million USD | 7.06% |
| 2006 FY | 156.25 Million USD | 630.34% |
| 2006 Q3 | 87.73 Million USD | 223.04% |
| 2006 Q4 | 156.25 Million USD | 78.1% |
| 2006 Q2 | 27.15 Million USD | 11.85% |
| 2006 Q1 | 24.28 Million USD | 13.49% |
| 2005 Q1 | 14.13 Million USD | 7.73% |
| 2005 FY | 21.39 Million USD | 63.06% |
| 2005 Q2 | 16.23 Million USD | 14.84% |
| 2005 Q4 | 21.39 Million USD | 12.62% |
| 2005 Q3 | 18.99 Million USD | 17.04% |
| 2004 Q2 | 13.42 Million USD | -6.34% |
| 2004 Q3 | 9.24 Million USD | -31.16% |
| 2004 Q4 | 13.12 Million USD | 41.96% |
| 2004 Q1 | 14.33 Million USD | 0.0% |
| 2004 FY | 13.12 Million USD | -8.25% |
| 2003 FY | 14.29 Million USD | 2.14% |
| 2002 FY | 14 Million USD | 0.0% |
| 2000 FY | 10.75 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -114.835% |
| Alkermes plc | 933.53 Million USD | 22.728% |
| Agenus Inc. | 462.29 Million USD | -56.04% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 82.191% |
| Aptorum Group Limited | 5.25 Million USD | -13622.693% |
| Ardelyx, Inc. | 130.76 Million USD | -451.659% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -50.79% |
| Bicycle Therapeutics plc | 224.41 Million USD | -221.447% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -454.002% |
| ChromaDex Corporation | 26.5 Million USD | -2621.314% |
| Chimerix, Inc. | 19.74 Million USD | -3553.411% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -1950.668% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -894.069% |
| CRISPR Therapeutics AG | 346.76 Million USD | -108.026% |
| Precision BioSciences, Inc. | 140.92 Million USD | -411.898% |
| Dyadic International, Inc. | 2.34 Million USD | -30719.033% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -4335.627% |
| Fortress Biotech, Inc. | 165.93 Million USD | -334.718% |
| Lantern Pharma Inc. | 2.73 Million USD | -26230.282% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -909.186% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -20342.681% |
| Incyte Corporation | 1.59 Billion USD | 54.696% |
| IO Biotech, Inc. | 17.55 Million USD | -4008.943% |
| Jaguar Health, Inc. | 45.86 Million USD | -1472.768% |
| Novavax, Inc. | 2.57 Billion USD | 71.956% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -1900.571% |
| Opthea Limited | 264.6 Million USD | -172.624% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -451.895% |
| ContextLogic Inc. | 206 Million USD | -250.178% |
| MiMedx Group, Inc. | 96.33 Million USD | -648.849% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -1402.157% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -20341.743% |
| NextCure, Inc. | 14.99 Million USD | -4710.069% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -17746.759% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -10703.744% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -1443.392% |
| Vaxcyte, Inc. | 167.44 Million USD | -330.797% |
| PDS Biotechnology Corporation | 33.25 Million USD | -2068.926% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -206.685% |
| Pharming Group N.V. | 244.07 Million USD | -195.553% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -5950.713% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -464.489% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -10817.747% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -10817.747% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -775.094% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -10759.04% |
| Acelyrin, Inc. | 86.35 Million USD | -735.369% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -55422.109% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -4916.802% |
| Summit Therapeutics Inc. | 125.25 Million USD | -475.909% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -7510.149% |
| Senti Biosciences, Inc. | 52.57 Million USD | -1272.175% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -948.848% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -376.111% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -36779.652% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -53912.088% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -218.018% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -7601.142% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -217.161% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -45.875% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -6509.547% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -2522.1% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -5859.388% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -48.246% |
| Immix Biopharma, Inc. | 3.72 Million USD | -19282.269% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -1807.77% |
| MEI Pharma, Inc. | 8.35 Million USD | -8533.944% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -2386.183% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -107.54% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -394.53% |
| Fortress Biotech, Inc. | 165.93 Million USD | -334.718% |
| Precigen, Inc. | 41.64 Million USD | -1632.221% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -1344.755% |
| AlloVir, Inc. | 45.01 Million USD | -1502.501% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -453.462% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -423.488% |
| ImmuCell Corporation | 18.81 Million USD | -3733.989% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -2455.679% |
| Onconetix, Inc. | 23.18 Million USD | -3011.9% |
| PureTech Health plc | 125.58 Million USD | -474.414% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -7959.955% |
| Elevation Oncology, Inc. | 34.28 Million USD | -2004.212% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -29403.722% |
| Seer, Inc. | 39.36 Million USD | -1732.506% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -1066.617% |
| Innoviva, Inc. | 568.55 Million USD | -26.878% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -2549.354% |
| ESSA Pharma Inc. | 3.49 Million USD | -20539.523% |
| GlycoMimetics, Inc. | 6.9 Million USD | -10351.438% |
| GT Biopharma, Inc. | 6.63 Million USD | -10775.411% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -172.842% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -164.929% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -758.503% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -7280.458% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -2555.107% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -22262.578% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -877.898% |
| Aptose Biosciences Inc. | 15.8 Million USD | -4463.095% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -6434.298% |
| Soligenix, Inc. | 7.27 Million USD | -9815.815% |
| Century Therapeutics, Inc. | 175.94 Million USD | -310.004% |
| Kura Oncology, Inc. | 51.66 Million USD | -1296.318% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -494.784% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -17353.811% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -10806.892% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -185.579% |
| Autolus Therapeutics plc | 263.9 Million USD | -173.341% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -6781.95% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -711.791% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -1438.127% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -104.436% |
| GRI Bio, Inc. | 2.69 Million USD | -26646.978% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -89003.182% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -2220.176% |
| IGM Biosciences, Inc. | 220.17 Million USD | -227.63% |
| INmune Bio, Inc. | 18.86 Million USD | -3724.441% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -181.257% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2607.646% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -26436.36% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -21891.082% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -1134.054% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -650.18% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -172.486% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 12.352% |
| Verastem, Inc. | 71.18 Million USD | -913.368% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -1366.907% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -1769.89% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -1374.221% |
| Histogen Inc. | 5.69 Million USD | -12562.208% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -16348.495% |
| Surrozen, Inc. | 8.14 Million USD | -8756.55% |
| Organovo Holdings, Inc. | 2.74 Million USD | -26150.582% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -229738.335% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -1182.887% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -4268.738% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -1311.592% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -87140.03% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -469.237% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -6570.921% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -378.077% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -27566.688% |
| Apollomics, Inc. | 14.15 Million USD | -4996.912% |
| Amarin Corporation plc | 279.58 Million USD | -158.011% |
| Mesoblast Limited | 188.79 Million USD | -282.083% |
| Turnstone Biologics Corp. | 14.14 Million USD | -4998.714% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -299.012% |
| Synaptogenix, Inc. | 5.52 Million USD | -12945.846% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -10750.872% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -324.064% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -8329.937% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -40947.506% |
| Exelixis, Inc. | 678.44 Million USD | -6.326% |
| Better Therapeutics, Inc. | 23.84 Million USD | -2925.61% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -339.734% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -21.399% |
| NLS Pharmaceutics AG | 10.68 Million USD | -6654.234% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -44329.594% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -1753.125% |
| Gritstone bio, Inc. | 125.91 Million USD | -472.881% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -4815.277% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -14076.044% |
| Avid Bioservices, Inc. | 275.66 Million USD | -161.679% |
| Insmed Incorporated | 1.66 Billion USD | 56.59% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -9275.666% |
| MediWound Ltd. | 27.18 Million USD | -2553.349% |
| OmniAb, Inc. | 87.4 Million USD | -725.362% |
| Alector, Inc. | 487.66 Million USD | -47.921% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -78.797% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -3815.148% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -1779.879% |
| Zai Lab Limited | 240.17 Million USD | -200.348% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -14.492% |
| Aura Biosciences, Inc. | 29.22 Million USD | -2368.149% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -658.718% |
| Immunic, Inc. | 25.36 Million USD | -2743.606% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -941.894% |
| Veracyte, Inc. | 93.71 Million USD | -669.712% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -27468.061% |
| FibroGen, Inc. | 585.72 Million USD | -23.157% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -4049.836% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -110356.67% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -12655.218% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 90.578% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -8699.293% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -758.544% |
| TG Therapeutics, Inc. | 169.08 Million USD | -326.629% |
| Galecto, Inc. | 5.89 Million USD | -12134.837% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -8607.943% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 72.45% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -2402.831% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -5615.601% |
| XBiotech Inc. | 8.39 Million USD | -8490.759% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -4815.277% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -1256.461% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -98.665% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -2583.254% |
| Theravance Biopharma, Inc. | 169 Million USD | -326.834% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 40.658% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -44.15% |
| Vaxxinity, Inc. | 30.94 Million USD | -2231.198% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 25.823% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -11860.756% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 3.203% |
| NexImmune, Inc. | 5.08 Million USD | -14088.298% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -194132.002% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -23360.217% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 89.85% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -13896.154% |
| Scopus BioPharma Inc. | 7.45 Million USD | -9577.006% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -2643.462% |
| Ainos, Inc. | 7.39 Million USD | -9655.805% |
| Pluri Inc. | 34.11 Million USD | -2014.699% |
| Prothena Corporation plc | 135.01 Million USD | -434.278% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -196.733% |
| Celularity Inc. | 102.92 Million USD | -600.838% |
| Rallybio Corporation | 9.43 Million USD | -7544.828% |
| Cue Biopharma, Inc. | 24.44 Million USD | -2850.976% |
| MeiraGTx Holdings plc | 319.99 Million USD | -125.433% |
| Omeros Corporation | 403.25 Million USD | -78.887% |
| Humacyte, Inc. | 114.67 Million USD | -529.042% |
| Immunocore Holdings plc | 228.15 Million USD | -216.169% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -14697.251% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -840.013% |
| Blueprint Medicines Corporation | 918.64 Million USD | 21.475% |
| CalciMedica, Inc. | 4.02 Million USD | -17808.788% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -4033.429% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -367.985% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -740.586% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -159.678% |
| Pulmatrix, Inc. | 15.96 Million USD | -4418.988% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -4473.423% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -2831.667% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -187.617% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -1320.403% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 40.414% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -2169.66% |
| Nutriband Inc. | 1.07 Million USD | -66760.07% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -6684.219% |
| Vor Biopharma Inc. | 59.1 Million USD | -1120.503% |
| Roivant Sciences Ltd. | 773.95 Million USD | 6.795% |
| Evogene Ltd. | 17.99 Million USD | -3909.817% |
| ProKidney Corp. | 29.21 Million USD | -2369.079% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -902.19% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -102223.886% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 61.811% |
| CorMedix Inc. | 11.91 Million USD | -5952.983% |
| BioLineRx Ltd. | 50.7 Million USD | -1322.756% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -382.651% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -715.647% |
| Atai Life Sciences N.V. | 49.16 Million USD | -1367.324% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -2215.61% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -3916.067% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -478.778% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -12658.507% |
| MediciNova, Inc. | 3.89 Million USD | -18436.713% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -3846.419% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -47855.481% |
| GeoVax Labs, Inc. | 3.51 Million USD | -20394.045% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -81.586% |
| Biomea Fusion, Inc. | 30.69 Million USD | -2250.492% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 73.496% |
| Mereo BioPharma Group plc | 15.96 Million USD | -4419.271% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -2211.996% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -1129.238% |
| Absci Corporation | 58.3 Million USD | -1137.25% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -3687.096% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -2149.91% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -877.593% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -724.578% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -2036.115% |
| Allakos Inc. | 74.79 Million USD | -864.483% |
| Imunon, Inc. | 8.53 Million USD | -8356.388% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -3105.929% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -528.302% |
| BioAtla, Inc. | 48.98 Million USD | -1372.596% |
| NLS Pharmaceutics AG | 10.68 Million USD | -6654.234% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -25857.755% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -452.331% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -4974.682% |
| XOMA Corporation | 145.58 Million USD | -395.512% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -2042.777% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -949.122% |
| aTyr Pharma, Inc. | 31.59 Million USD | -2183.021% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -1066.825% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -1504.283% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -1390.364% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -25034.704% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -8742.417% |
| Akari Therapeutics, Plc | 4.58 Million USD | -15636.606% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -3967.9% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 56.267% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -178496.611% |
| UroGen Pharma Ltd. | 243.52 Million USD | -196.221% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -124.664% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -26021.704% |
| Orgenesis Inc. | 35.53 Million USD | -1930.015% |
| Entera Bio Ltd. | 1.37 Million USD | -52210.805% |
| GH Research PLC | 6.7 Million USD | -10665.05% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -10508.324% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -3731.754% |
| Xencor, Inc. | 283.55 Million USD | -154.397% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -24060.902% |
| Replimune Group, Inc. | 113.21 Million USD | -537.17% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -19099.947% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -596.77% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -178496.611% |
| Portage Biotech Inc. | 4.45 Million USD | -16110.472% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -47855.481% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -3029.57% |
| OncoCyte Corporation | 49.29 Million USD | -1363.276% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -17337.757% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -90355.232% |
| Purple Biotech Ltd. | 10 Million USD | -7110.055% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -12367.439% |
| scPharmaceuticals Inc. | 57.26 Million USD | -1159.786% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -5723.093% |
| HilleVax, Inc. | 78.9 Million USD | -814.175% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -14184.475% |
| Tharimmune, Inc. | 1.81 Million USD | -39643.676% |
| Genprex, Inc. | 3.25 Million USD | -22067.176% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -2560.002% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -13677.044% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -350077.67% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -201090.914% |
| OKYO Pharma Limited | 7.42 Million USD | -9620.805% |
| Savara Inc. | 37.19 Million USD | -1839.573% |
| Curis, Inc. | 57.61 Million USD | -1152.111% |
| Daré Bioscience, Inc. | 26.32 Million USD | -2639.726% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -1740.229% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -49856.094% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -3364.941% |
| BeiGene, Ltd. | 2.23 Billion USD | 67.706% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -3288.317% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -174.914% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -3290.834% |
| Erasca, Inc. | 78.61 Million USD | -817.64% |
| bluebird bio, Inc. | 424.62 Million USD | -69.883% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -109989.859% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 61.834% |
| DBV Technologies S.A. | 42.8 Million USD | -1585.435% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -109989.859% |
| Moderna, Inc. | 4.57 Billion USD | 84.222% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -10212.595% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -43460.749% |
| Molecular Templates, Inc. | 31.17 Million USD | -2214.222% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -4125.929% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -22.66% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -479.387% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -2529.172% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -1878.731% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -1196.605% |
| MacroGenics, Inc. | 154.2 Million USD | -367.791% |
| RenovoRx, Inc. | 4.46 Million USD | -16052.396% |
| Adicet Bio, Inc. | 37.12 Million USD | -1843.335% |
| Prime Medicine, Inc. | 60.78 Million USD | -1086.848% |
| Aditxt, Inc. | 28.53 Million USD | -2428.309% |
| Adagene Inc. | 45.16 Million USD | -1497.026% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -399104.21% |
| Quantum-Si incorporated | 26.63 Million USD | -2608.745% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -3.412% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -23610.13% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -527.488% |
| SciSparc Ltd. | 1.59 Million USD | -45126.708% |
| Vericel Corporation | 127.7 Million USD | -464.869% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -12862.799% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -745.105% |
| Generation Bio Co. | 171.63 Million USD | -320.303% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -6145.593% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -1624.477% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -185.466% |
| Invivyd, Inc. | 51.71 Million USD | -1294.941% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -684.29% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -10988.98% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -855.502% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -70552.889% |
| 2seventy bio, Inc. | 310.12 Million USD | -132.604% |
| ADMA Biologics, Inc. | 193.97 Million USD | -271.884% |
| Clene Inc. | 38.95 Million USD | -1751.983% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -1896.427% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -180.713% |
| GeoVax Labs, Inc. | 3.51 Million USD | -20394.045% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -279.142% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -5822.71% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -263.735% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -5815.357% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -1399.379% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -1265.163% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -95.041% |
| Evaxion Biotech A/S | 17.61 Million USD | -3994.604% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -348.251% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -370.909% |
| Trevena, Inc. | 48.26 Million USD | -1394.687% |
| Surrozen, Inc. | 8.14 Million USD | -8756.55% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -3240.431% |
| Cingulate Inc. | 10.36 Million USD | -6862.411% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -26131.491% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -1834.372% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -20013.257% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -5385.673% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -127.416% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -2802.998% |
| Clearmind Medicine Inc. | 3.61 Million USD | -19882.393% |
| Kronos Bio, Inc. | 54.2 Million USD | -1230.909% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -1433.418% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -3069.484% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -3494.071% |
| Statera Biopharma, Inc. | 22.67 Million USD | -3081.124% |
| ImmunityBio, Inc. | 1.09 Billion USD | 33.843% |
| Korro Bio, Inc. | 51.75 Million USD | -1293.89% |
| Kineta, Inc. | 7.22 Million USD | -9888.452% |
| BioVie Inc. | 9.7 Million USD | -7335.13% |
| Codexis, Inc. | 49.94 Million USD | -1344.292% |
| Celularity Inc. | 102.92 Million USD | -600.838% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -649.495% |
| Celcuity Inc. | 51.45 Million USD | -1302.07% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -208874.084% |
| Cibus, Inc. | 206.11 Million USD | -249.979% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -1598.331% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -2638.775% |
| IN8bio, Inc. | 8.77 Million USD | -8123.507% |
| Kodiak Sciences Inc. | 213.59 Million USD | -237.732% |
| Annexon, Inc. | 47.11 Million USD | -1430.978% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -705.626% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -648.522% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -5169.676% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 72.291% |
| Eyenovia, Inc. | 19.78 Million USD | -3546.895% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -307.353% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -9291.564% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -2893.344% |
| Arcellx, Inc. | 339.75 Million USD | -112.321% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -5962.918% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -193.788% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -7443.302% |
| Moolec Science SA | 13.94 Million USD | -5072.804% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -1571.686% |
| Geron Corporation | 146.12 Million USD | -393.657% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -1327.543% |
| Royalty Pharma plc | 6.29 Billion USD | 88.545% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -1713.571% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -244924.218% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -29220.46% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -281.36% |
| Humacyte, Inc. | 114.67 Million USD | -529.042% |
| Structure Therapeutics Inc. | 29.05 Million USD | -2383.102% |
| 89bio, Inc. | 59.96 Million USD | -1103.019% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -2625.942% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -60214.883% |
| Genelux Corporation | 8.42 Million USD | -8467.292% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -10421.674% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -429.175% |
| Notable Labs, Ltd. | 4.42 Million USD | -16194.692% |
| Liquidia Corporation | 73.13 Million USD | -886.308% |
| Mustang Bio, Inc. | 17.61 Million USD | -3994.251% |
| Immunovant, Inc. | 48.95 Million USD | -1373.529% |
| Quantum-Si incorporated | 26.63 Million USD | -2608.745% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -1779.389% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -23147.374% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -876.653% |
| Acasti Pharma Inc. | 11.55 Million USD | -6141.81% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -3090.794% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -26436.36% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -1856.141% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -52831.007% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -11733.432% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -2804.635% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -3011.482% |
| PepGen Inc. | 34.63 Million USD | -1983.007% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -5840.102% |
| United Therapeutics Corporation | 1.18 Billion USD | 38.981% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -10228.837% |
| Solid Biosciences Inc. | 38.45 Million USD | -1775.724% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -8329.937% |
| Immuneering Corporation | 12 Million USD | -5907.201% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -229738.335% |
| Silo Pharma, Inc. | 1.56 Million USD | -45868.253% |
| Belite Bio, Inc | 4.21 Million USD | -17030.515% |
| XOMA Corporation | 145.58 Million USD | -395.512% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -29610.297% |
| Bionomics Limited | 10.15 Million USD | -7000.953% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -3256.596% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -3048.283% |
| uniQure N.V. | 624.01 Million USD | -15.6% |
| Cassava Sciences, Inc. | 14.19 Million USD | -4981.832% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -399104.21% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -323.874% |
| Forte Biosciences, Inc. | 3.66 Million USD | -19577.196% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -276727.729% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -10591.656% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -9291.564% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -4049.836% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -6725.946% |
| Altimmune, Inc. | 16.54 Million USD | -4261.079% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -16.781% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -3048.283% |
| Compugen Ltd. | 55.77 Million USD | -1193.35% |
| Peak Bio, Inc. | 20.75 Million USD | -3375.899% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -553.039% |
| Benitec Biopharma Inc. | 4.96 Million USD | -14437.807% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -357.015% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -859.595% |
| Zura Bio Limited | 21.29 Million USD | -3287.967% |
| PolyPid Ltd. | 17.46 Million USD | -4029.643% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -541.79% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -859.595% |
| Instil Bio, Inc. | 99.8 Million USD | -622.804% |
| argenx SE | 444.95 Million USD | -62.123% |
| Immunome, Inc. | 28.65 Million USD | -2417.154% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -8552.585% |
| Verona Pharma plc | 58.84 Million USD | -1125.958% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -4884.219% |
| Shattuck Labs, Inc. | 14.85 Million USD | -4754.741% |
| CervoMed Inc. | 2.59 Million USD | -27690.305% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -14700.287% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -5563.992% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -6747.328% |
| Moolec Science SA | 13.94 Million USD | -5072.804% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -30681.513% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -1197.531% |
| AnaptysBio, Inc. | 364.28 Million USD | -98.022% |
| Design Therapeutics, Inc. | 11.95 Million USD | -5933.506% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -5587.212% |
| NeurAxis, Inc. | 1.91 Million USD | -37613.771% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -1753.077% |
| Lumos Pharma, Inc. | 13.33 Million USD | -5310.38% |
| Achilles Therapeutics plc | 19.08 Million USD | -3679.358% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -4884.219% |
| 180 Life Sciences Corp. | 5.38 Million USD | -13290.347% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -2958.192% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -3069.484% |
| Nutriband Inc. | 1.07 Million USD | -66760.07% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -2257.559% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -4871.167% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -79.769% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -2121.433% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -5428.092% |
| Palisade Bio, Inc. | 2.73 Million USD | -26236.838% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -13632.458% |
| Beam Therapeutics Inc. | 478.38 Million USD | -50.792% |
| Neurogene Inc. | 36.54 Million USD | -1873.696% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -81.27% |
| AEON Biopharma, Inc. | 159.88 Million USD | -351.167% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -1413.885% |
| Sesen Bio, Inc. | 30.98 Million USD | -2228.189% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -2678.653% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -9388.891% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -268.537% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -275.6% |
| Athira Pharma, Inc. | 30.05 Million USD | -2299.993% |
| Vaccinex, Inc. | 5.94 Million USD | -12040.121% |
| HCW Biologics Inc. | 15.05 Million USD | -4692.511% |
| XOMA Corporation | 145.58 Million USD | -395.512% |
| Nektar Therapeutics | 267.04 Million USD | -170.128% |
| Arvinas, Inc. | 644.6 Million USD | -11.909% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -3967.9% |
| Merus N.V. | 102.15 Million USD | -606.176% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -392.905% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -658.375% |
| Rezolute, Inc. | 11.73 Million USD | -6047.656% |
| Clene Inc. | 38.95 Million USD | -1751.983% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -25234.378% |
| BeyondSpring Inc. | 48.26 Million USD | -1394.471% |
| Synlogic, Inc. | 32.89 Million USD | -2092.935% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -4836.468% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -44047.246% |
| Peak Bio, Inc. | 20.75 Million USD | -3375.899% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -1036.743% |
| Krystal Biotech, Inc. | 39.71 Million USD | -1716.402% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -91.525% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -624.489% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -166602.717% |
| Ikena Oncology, Inc. | 22.33 Million USD | -3129.756% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -34481.304% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -603.154% |
| Gossamer Bio, Inc. | 249.14 Million USD | -189.534% |
| CohBar, Inc. | 1.03 Million USD | -69689.036% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -6648.676% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -3687.096% |
| Legend Biotech Corporation | 589.93 Million USD | -22.279% |
| Mural Oncology plc | 37.92 Million USD | -1801.935% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -443.869% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -31327.523% |
| Disc Medicine, Inc. | 22.87 Million USD | -3053.513% |
| Champions Oncology, Inc. | 28.03 Million USD | -2473.091% |
| REGENXBIO Inc. | 262.22 Million USD | -175.091% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -21373.367% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -5655.274% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -5270.652% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -3301.867% |
| Vaxart, Inc. | 34.02 Million USD | -2020.106% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -3437.97% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -2428.281% |
| Cellectis S.A. | 249.57 Million USD | -189.038% |
| Longeveron Inc. | 5.33 Million USD | -13416.32% |
| Repare Therapeutics Inc. | 41.81 Million USD | -1624.972% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 70.009% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -1094.948% |
| Revolution Medicines, Inc. | 262.39 Million USD | -174.914% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -34136.64% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -8262.694% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -6012.753% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -5036.837% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -33436.309% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 85.992% |
| Denali Therapeutics Inc. | 122.96 Million USD | -486.653% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -12862.799% |
| Veru Inc. | 32.81 Million USD | -2098.435% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -10401.762% |
| Cingulate Inc. | 10.36 Million USD | -6862.411% |
| Passage Bio, Inc. | 39.26 Million USD | -1737.313% |
| Context Therapeutics Inc. | 4.19 Million USD | -17109.328% |
| Exicure, Inc. | 8.54 Million USD | -8338.016% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -2344.646% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -6779.325% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -3172.837% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -342.594% |
| Nuvalent, Inc. | 31.82 Million USD | -2166.807% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -11239.332% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -1044.626% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -3907.589% |
| OmniAb, Inc. | 87.4 Million USD | -725.362% |
| Anew Medical, Inc. | 8.24 Million USD | -8652.531% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -1783.999% |
| Lipocine Inc. | 2.63 Million USD | -27311.387% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -2645.76% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -1693.907% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2607.646% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -737.298% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -13256.156% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -771.773% |
| Ocugen, Inc. | 23.98 Million USD | -2907.822% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -1454.434% |
| Q32 Bio Inc. | 233.12 Million USD | -209.429% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -7856.828% |
| Alumis Inc. Common Stock | 53.5 Million USD | -1248.297% |
| Equillium, Inc. | 27.95 Million USD | -2480.27% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -249.174% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -12720.49% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -11662.103% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -358.517% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -938.938% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -7132.319% |
| Dominari Holdings Inc. | 4.63 Million USD | -15463.452% |
| Edesa Biotech, Inc. | 1.84 Million USD | -39069.826% |
| vTv Therapeutics Inc. | 29.56 Million USD | -2339.767% |
| Bio-Techne Corporation | 744.34 Million USD | 3.086% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -472.063% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -109.422% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -1677.858% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -2391.163% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -681.037% |
| Nkarta, Inc. | 105.6 Million USD | -583.112% |
| BioCardia, Inc. | 4.59 Million USD | -15616.035% |
| Iterum Therapeutics plc | 32.66 Million USD | -2108.579% |